DE69105767D1 - Bilobalid-Phospholipid-Komplexe, ihre Anwendung und Zusammensetzungen enthaltend diese. - Google Patents
Bilobalid-Phospholipid-Komplexe, ihre Anwendung und Zusammensetzungen enthaltend diese.Info
- Publication number
- DE69105767D1 DE69105767D1 DE69105767T DE69105767T DE69105767D1 DE 69105767 D1 DE69105767 D1 DE 69105767D1 DE 69105767 T DE69105767 T DE 69105767T DE 69105767 T DE69105767 T DE 69105767T DE 69105767 D1 DE69105767 D1 DE 69105767D1
- Authority
- DE
- Germany
- Prior art keywords
- inflammatory
- bilobalid
- treatment
- application
- bilobalide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title 1
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 230000002757 inflammatory effect Effects 0.000 abstract 2
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 229930004725 sesquiterpene Natural products 0.000 abstract 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 abstract 1
- 238000007910 systemic administration Methods 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
- C07F9/106—Adducts, complexes, salts of phosphatides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cosmetics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT19324A IT1238684B (it) | 1990-02-09 | 1990-02-09 | Derivati del bilobalide,loro usi e formulazioni che li contegono |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69105767D1 true DE69105767D1 (de) | 1995-01-26 |
| DE69105767T2 DE69105767T2 (de) | 1995-04-27 |
Family
ID=11156741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69105767T Expired - Fee Related DE69105767T2 (de) | 1990-02-09 | 1991-02-07 | Bilobalid-Phospholipid-Komplexe, ihre Anwendung und Zusammensetzungen enthaltend diese. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5202313A (de) |
| EP (1) | EP0441279B1 (de) |
| JP (1) | JP3036881B2 (de) |
| KR (1) | KR0170773B1 (de) |
| AT (1) | ATE115585T1 (de) |
| CA (1) | CA2035951C (de) |
| DE (1) | DE69105767T2 (de) |
| DK (1) | DK0441279T3 (de) |
| ES (1) | ES2066239T3 (de) |
| HK (1) | HK160795A (de) |
| IT (1) | IT1238684B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5895785A (en) * | 1987-10-20 | 1999-04-20 | Ruth Korth | Treatment and prevention of disorders mediated by LA-paf or endothelial cells |
| EP0540766A1 (de) * | 1991-11-04 | 1993-05-12 | Korth, Ruth-Maria, Dr. med | Behandlung von Eosinophil-mediierten Erkrankungen mit PAF-Antagonisten, und Verfahren zur Bestimmung deren Effektivität |
| ATE221779T1 (de) * | 1991-11-04 | 2002-08-15 | Ruth-Maria Korth | Behandlung und vorbeugung von erhöhten lyso-paf- spiegel mediierten mentalen erkrankungen mit paf- antagonisten |
| GB9202993D0 (en) * | 1992-02-13 | 1992-03-25 | Indena Spa | Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use |
| GB9205670D0 (en) * | 1992-03-16 | 1992-04-29 | Indena Spa | New derivatives of physostigmine,their use and pharmaceutical formulations containing them |
| US5456912A (en) * | 1993-12-28 | 1995-10-10 | The Regents Of The University Of California | Non-methylene interrupted fatty acids as immunomodulators |
| US6379714B1 (en) | 1995-04-14 | 2002-04-30 | Pharmaprint, Inc. | Pharmaceutical grade botanical drugs |
| CA2331918A1 (en) * | 1998-06-11 | 1999-12-16 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Protecting neurons from ischemia |
| US7494643B2 (en) * | 2003-07-22 | 2009-02-24 | Rendon Marta I | Method and topical composition for the treatment of hyperpigmented skin |
| EP1559430B1 (de) | 2004-01-29 | 2009-04-15 | INDENA S.p.A. | Verwendung von Ginkgokomplexen zur Verbesserung von kognitiven Leistungen und Linderung der mentalen Ermüdung |
| ITMI20060136A1 (it) * | 2006-01-27 | 2007-07-28 | Pharmextracta S R L | Composizioni a base di derivati della ginkgo biloba per il trattamento di condizioni asmatiche e allergiche |
| ITMI20071492A1 (it) | 2007-07-24 | 2009-01-25 | S I I T Srl Servizio Internazi | "composizioni per il trattamento e la prevenzione di condizioni di vertigine e acufeni comprendenti citicolina, estratto di ginkgo biloba e flavoni dimerici di ginkgo biloba" |
| IT1397386B1 (it) | 2010-01-12 | 2013-01-10 | Indena Spa | Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso. |
| IT1402672B1 (it) | 2010-11-08 | 2013-09-13 | Medestea Biotech S P A | Composizioni comprendenti principi attivi di origine vegetale associati o meno a promotori e/o protettori di ossido nitrico per il trattamento e la prevenzione dei deficit erettili e dell' impotenza e per il potenziamento della performance sportiva |
| ITTO20110901A1 (it) | 2011-10-10 | 2013-04-11 | Medestea Biotech S P A | Composizione sinergica per la prevenzione ed il trattamento di disturbi connessi all'invecchiamento |
| CN109851634B (zh) * | 2018-12-25 | 2020-12-22 | 华东师范大学 | 手性单膦配体Yu-Phos及其全构型的制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3338995A1 (de) * | 1983-10-27 | 1985-05-09 | Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe | Bilobalid enthaltende arzneimittel |
| DD213672A1 (de) * | 1983-03-04 | 1984-09-19 | Akad Wissenschaften Ddr | Verfahren zur herstellung von gibberellin-derivaten mit 13,16-anneliertem oxathiaphospholan-ring |
| IT1215291B (it) * | 1985-07-17 | 1990-01-31 | Inverni Della Beffa Spa | Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche. |
| IT1201149B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche |
| IT1203515B (it) * | 1987-02-26 | 1989-02-15 | Indena Spa | Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono |
| JPH0231646A (ja) * | 1988-07-21 | 1990-02-01 | Daicel Chem Ind Ltd | イチョウ抽出物入りチョコレート |
| JPH0231648A (ja) * | 1988-07-21 | 1990-02-01 | Daicel Chem Ind Ltd | イチョウ抽出物入りチューインガム |
-
1990
- 1990-02-09 IT IT19324A patent/IT1238684B/it active IP Right Grant
-
1991
- 1991-02-06 US US07/651,598 patent/US5202313A/en not_active Expired - Lifetime
- 1991-02-07 ES ES91101425T patent/ES2066239T3/es not_active Expired - Lifetime
- 1991-02-07 DK DK91101425.6T patent/DK0441279T3/da active
- 1991-02-07 EP EP91101425A patent/EP0441279B1/de not_active Expired - Lifetime
- 1991-02-07 KR KR1019910002192A patent/KR0170773B1/ko not_active IP Right Cessation
- 1991-02-07 DE DE69105767T patent/DE69105767T2/de not_active Expired - Fee Related
- 1991-02-07 CA CA002035951A patent/CA2035951C/en not_active Expired - Fee Related
- 1991-02-07 JP JP3102195A patent/JP3036881B2/ja not_active Expired - Fee Related
- 1991-02-07 AT AT91101425T patent/ATE115585T1/de not_active IP Right Cessation
-
1995
- 1995-10-12 HK HK160795A patent/HK160795A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IT9019324A0 (it) | 1990-02-09 |
| CA2035951C (en) | 2001-07-31 |
| IT1238684B (it) | 1993-09-01 |
| HK160795A (en) | 1995-10-20 |
| JP3036881B2 (ja) | 2000-04-24 |
| EP0441279B1 (de) | 1994-12-14 |
| DE69105767T2 (de) | 1995-04-27 |
| IT9019324A1 (it) | 1991-08-09 |
| EP0441279A1 (de) | 1991-08-14 |
| CA2035951A1 (en) | 1991-08-10 |
| ES2066239T3 (es) | 1995-03-01 |
| ATE115585T1 (de) | 1994-12-15 |
| KR0170773B1 (ko) | 1999-03-30 |
| KR910015308A (ko) | 1991-09-30 |
| US5202313A (en) | 1993-04-13 |
| DK0441279T3 (da) | 1995-05-08 |
| JPH06145174A (ja) | 1994-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69105767D1 (de) | Bilobalid-Phospholipid-Komplexe, ihre Anwendung und Zusammensetzungen enthaltend diese. | |
| DE69738935D1 (de) | Zusammensetzungen enthaltend Thalidomide und Dexamethason für die Behandlung von Krebs | |
| SE7903186L (sv) | Cerebralverksamt medel | |
| IT1201149B (it) | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche | |
| FI20105844A (fi) | Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon | |
| RU93004860A (ru) | Гетероциклические соединения, способ их получения, использование и фармацевтическая композиция | |
| DE3480053D1 (en) | A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor | |
| DK0579996T3 (da) | 5,10-Methylentetrahydrofolsyrecyclodextrin-inklusionsforbindelser | |
| EP0299424A3 (en) | Thiosulfinic-acid derivatives, their use in the treatment of inflammatory diseases, and medicaments containing these substances | |
| ES2096203T3 (es) | Nuevos derivados de fisostigmina, su uso y formulaciones farmaceuticas que los contienen. | |
| IT1237509B (it) | Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche | |
| ATE275953T1 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
| DK0950053T3 (da) | Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater | |
| ATE192748T1 (de) | Neue alkaloidderivate, ihre verwendung und diese enthaltende pharmazeutische formulierungen | |
| DE69313534D1 (de) | Digitoxigenin und Dihydrodigitoxigenin 3-beta-Derivate und pharmazeutische Präparate davon, zur Behandlung von hypertonie | |
| RU93049414A (ru) | Производные бенз(е)индена | |
| IT1224897B (it) | Composizione farmaceutica per il trattamento delle affezioni parodontali | |
| ITMI911841A0 (it) | Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
| ITMI911842A0 (it) | Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
| ITMI912027A0 (it) | Derivati dell'eserolina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
| ITMI911713A0 (it) | Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |